We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ipsen announced Wednesday that CEO David Meek has resigned from his position and will assume the chief executive role at FerGene, a new gene therapy company recently launched by Ferring Pharmaceuticals and Blackstone Life Sciences, effective January 14 ne
FerGene, a new gene therapy company formed by Ferring Pharmaceuticals and Blackstone Life Sciences, announced positive results from the pivotal Phase 3 clinical trial ...